Stryker EBITDA 2010-2024 | SYK
Stryker annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Stryker EBITDA for the quarter ending December 31, 2024 was $845M, a 43.93% decline year-over-year.
- Stryker EBITDA for the twelve months ending December 31, 2024 was $4.739B, a 3.6% decline year-over-year.
- Stryker 2024 annual EBITDA was $4.739B, a 3.6% decline from 2023.
- Stryker 2023 annual EBITDA was $4.916B, a 28.05% increase from 2022.
- Stryker 2022 annual EBITDA was $3.839B, a 7.41% increase from 2021.
Stryker Annual EBITDA (Millions of US $) |
2024 |
$4,739 |
2023 |
$4,916 |
2022 |
$3,839 |
2021 |
$3,574 |
2020 |
$3,035 |
2019 |
$3,491 |
2018 |
$3,260 |
2017 |
$2,939 |
2016 |
$2,721 |
2015 |
$2,258 |
2014 |
$1,624 |
2013 |
$1,563 |
2012 |
$2,018 |
2011 |
$1,846 |
2010 |
$1,916 |
2009 |
$1,979 |
Stryker Quarterly EBITDA (Millions of US $) |
2024-12-31 |
$845 |
2024-09-30 |
$1,353 |
2024-06-30 |
$1,309 |
2024-03-31 |
$1,232 |
2023-12-31 |
$1,507 |
2023-09-30 |
$1,193 |
2023-06-30 |
$1,224 |
2023-03-31 |
$992 |
2022-12-31 |
$1,067 |
2022-09-30 |
$1,058 |
2022-06-30 |
$1,025 |
2022-03-31 |
$689 |
2021-12-31 |
$1,057 |
2021-09-30 |
$809 |
2021-06-30 |
$973 |
2021-03-31 |
$735 |
2020-12-31 |
$972 |
2020-09-30 |
$1,057 |
2020-06-30 |
$173 |
2020-03-31 |
$833 |
2019-12-31 |
$1,139 |
2019-09-30 |
$822 |
2019-06-30 |
$812 |
2019-03-31 |
$718 |
2018-12-31 |
$874 |
2018-09-30 |
$761 |
2018-06-30 |
$858 |
2018-03-31 |
$767 |
2017-12-31 |
$883 |
2017-09-30 |
$688 |
2017-06-30 |
$662 |
2017-03-31 |
$706 |
2016-12-31 |
$821 |
2016-09-30 |
$634 |
2016-06-30 |
$645 |
2016-03-31 |
$621 |
2015-12-31 |
$756 |
2015-09-30 |
$479 |
2015-06-30 |
$523 |
2015-03-31 |
$500 |
2014-12-31 |
$564 |
2014-09-30 |
$547 |
2014-06-30 |
$291 |
2014-03-31 |
$222 |
2013-12-31 |
$512 |
2013-09-30 |
$226 |
2013-06-30 |
$401 |
2013-03-31 |
$424 |
2012-12-31 |
$532 |
2012-09-30 |
$488 |
2012-06-30 |
$452 |
2012-03-31 |
$546 |
2011-12-31 |
$219 |
2011-09-30 |
$568 |
2011-06-30 |
$521 |
2011-03-31 |
$538 |
2010-12-31 |
$252 |
2010-09-30 |
$572 |
2010-06-30 |
$547 |
2010-03-31 |
$546 |
2009-12-31 |
$618 |
2009-09-30 |
$500 |
2009-06-30 |
$390 |
2009-03-31 |
$471 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$142.748B |
$22.595B |
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
|